858 Therapeutics, Inc. — Form D
858 Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-11. The offering totals $50.4M, of which $25.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-07-11
- Form: D
- Accession: 0001806356-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $50.4M
- Amount sold: $25.2M
- Remaining: $25.2M
- Investors: 12
- Date of first sale: 2024-06-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-518431
Issuer
- Name: 858 Therapeutics, Inc.
- CIK: 0001806356
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3115 Merryfield Row, SAN DIEGO, CA, 92121
- Phone: 858-987-8380
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Ali Behbahani | Director | Littleton, CO |
| Jane Huang | Director | San Diego, CA |
| Stafford Jeffrey | Director | San Diego, CA |
| Monal Mehta | Director | San Diego, CA |
| Clare Ozawa | Director | South San Francisco, CA |
| Katherine Bell-McGuinn | Executive Officer | San Diego, CA |
| Stafford Jeffrey | Executive Officer | San Diego, CA |
| James Veal | Executive Officer | San Diego, CA |
| Carlo Rizzuto | Director | Littleton, CO |
| Ali A Behbahani | Director | San Diego, CA |
| Jeffrey A Stafford | Director | San Diego, CA |
| Jeffrey A Stafford | Executive Officer | San Diego, CA |
| Clare J Ozawa | Director | San Diego, CA |
| James J Veal | Executive Officer | San Diego, CA |
| BRADLEY J BOLZON | Director | MENLO PARK, CA |
Other filings by this issuer (2)
More